Bill Doyle

MBA ‘92, Harvard University
S.B., Materials Science and Engineering, MIT

Bill is the Executive Chairman of Novocure Ltd., a commercial stage oncology company pioneering Tumor Treating Fields therapy for solid tumor cancers and the Executive Chairman of Blink Health LLC, an e-commerce platform providing access to prescription drugs for all Americans. Bill is also the lead independent director of Minerva Neuroscience and a director of Optinose, Inc. Previously, Bill was a member of Johnson & Johnson’s Medical Devices and Diagnostics Group Operating Committee with responsibility for licensing and acquisitions and R&D.